Data protection Impressum

Life sciences

The Institute of Life Technologies of the HES-SO Valais/Wallis has forged a five-year collaboration with Debiopharm Research & Manufacturing to develop new targeted antibody fragment vectorization technologies.

HES-SO Valais-Wallis and Debiopharm partner up to battle cancer

4 October 2023

Nagi Bioscience is at the cusp of redefining the landscape of next-generation drug discovery and chemical testing technologies, placing humane testing solutions within arm’s reach of the global scientific community.

Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing

3 October 2023

With Atinary’s SDLabs, individuals or organizations can effortlessly incorporate ML into their existing workflows, with or without the utilization of robots, or in a simulation environment, to enhance and expedite R&D operations immediately.

Atinary Technologies raises USD 5 million to accelerate material and molecular innovation

3 October 2023

ONWARD’s ARC therapy helps enable people with spinal cord injury to move again.

ONWARD advances into the US Federal Health arena by helping disabled veterans

20 September 2023

Multiwave is on the verge of FDA approval for MGNTQÔ, its device described as the world's lightest portable MRI scanner.

Multiwave Technologies secures CHF 3.8 million for its light portable MRI device

19 September 2023

The Vaud-based biotech start-up, ranking first in the TOP 100 Swiss Startup Award 2023, harnesses the dark genome to craft precise RNA therapies for disease-modifying cell states.

HAYA Therapeutics triumphs at the 13th TOP 100 Swiss Startup Award

11 September 2023

ten23 Health, known for its commitment to delivering high-quality pharmaceutical services from its sites in Basel and BioArk in Visp, has recently made two major announcements which are set to make waves in the pharmaceutical sector.

ten23 health boosts sterile production capacity and introduces new quality control services

5 September 2023

Neurosoft’s recent achievements set the stage for innovative treatment methods and heightened diagnostic capabilities for severe neurological disorders.

Neurosoft breaks new ground with it pioneering brain interface technology

4 September 2023

The Pôle Santé campus will bring together the expertise of the HES-SO Valais-Wallis, EPFL, The Ark Foundation, the Valais Health Observatory and SpArk, the center of excellence for movement science and technology.

Sion’s Pôle Santé takes shape with the laying of the first stone

23 August 2023

Backed by its parent company Nanobacterie's fourth-place in nanomedicine patent rankings by Marks and Clerk, AlphaOnco Swiss channels the synergy of Franco-Swiss collaboration to bring forth groundbreaking cancer treatments.

Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking

23 August 2023

1 … 16 17 18 19 20 21 22 23 24 … 43